Article(id=1326654863930405682, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326654653699306189, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.04.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1724774400000, receivedDateStr=2024-08-28, revisedDate=1739289600000, revisedDateStr=2025-02-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228767615, onlineDateStr=2026-11-09, pubDate=1744214400000, pubDateStr=2025-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228767615, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228767615, creator=13701087609, updateTime=1794228767615, updator=13701087609, issue=Issue{id=1326654653699306189, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='4', pageStart='315', pageEnd='428', issueExtLink='null', onlineDate='null', pubDate='1744214400000', pubDateStr='2025-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228717492, creator='13701087609', updateTime=1794273058269, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840632833848267, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326654653699306189, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840632838042572, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326654653699306189, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=411, endPage=415, ext={EN=ArticleExt(id=1326654864123343667, articleId=1326654863930405682, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Evaluation of the clinical efficacy of methylbardoxolone in the treatment of chronic kidney disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Oxidative stress and inflammation are common factors that lead to the progression of chronic kidney disease (CKD) to end-stage renal disease (ESRD), and methylbardoxolone is an agonist of antioxidant and anti-inflammatory factors such nuclear factor erythroid-related factor 2. It can increase the glomerular filtration rate (GFR) of patients with CKD. Methylbardoxolone has a good effect in increasing GFR. However, because it can increase the risk of cardiovascular events and proteinuria, and fails to improve the incidence of ESRD, it ultimately failed to become a therapeutic drug for CKD. This article reviewed the effects of methylbardoxolone in clinical trials of CKD drugs caused by multiple factors, aiming to provide a reference for its application.

, authors=Xuan HU1, Fan ZHAO1, Bingzheng SHEN2, Ke SU1, *, authorsList=Xuan HU, Fan ZHAO, Bingzheng SHEN, Ke SU, authorCompany=null, correspAuthors=Ke SU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326654864358224693, articleId=1326654863930405682, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=甲基巴多索隆对慢性肾脏病临床效果评价, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

氧化应激和炎症是导致慢性肾脏病(chronic kidney disease,CKD)进展至终末期肾病(end-stage renal disease,ESRD)的共同因素,而甲基巴多索隆是一种抗氧化和抗炎因子核因子红细胞系2相关因子激动剂,可提高CKD患者肾小球滤过率,但因其可增加心血管事件、蛋白尿发生风险,未能改善ESRD发生率,故最终未能成为CKD治疗药物。现综述甲基巴多索隆在多种因素引发的CKD药物临床试验中的影响,旨在为临床应用提供参考。

, authors=虎璇1, 赵凡1, 沈秉正2, 苏可1, *, authorsList=虎璇, 赵凡, 沈秉正, 苏可, authorCompany=null, correspAuthors=苏可, authorNote=

虎璇,硕士研究生,研究方向:糖尿病肾病诊治。

, correspAuthorsNote=
苏可,硕士生导师,副主任医师,研究方向:糖尿病肾病诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=mrNzp9oGrDM7tbZuFnGONw==, magXml=TlV3aLr/Wmya48RT6WlRGA==, pdfUrl=null, pdf=sSsMPTkbp4epJKwAZtAT6g==, pdfFileSize=944969, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=3Ew/6MvYtAw1zAtM6oHNlg==, mapNumber=null, fund=null)}, authors=[Author(id=1326654864840569662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654864945427264, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654864840569662, language=EN, stringName=Xuan HU, firstName=Xuan, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654865008341825, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654864840569662, language=CN, stringName=虎璇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.武汉大学人民医院肾内科,湖北 武汉 430060, bio={"content":"

虎璇,硕士研究生,研究方向:糖尿病肾病诊治。

"}, bioImg=null, bioContent=

虎璇,硕士研究生,研究方向:糖尿病肾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)])]), Author(id=1326654865088033603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654865234834245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865088033603, language=EN, stringName=Fan ZHAO, firstName=Fan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654865293554502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865088033603, language=CN, stringName=赵凡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.武汉大学人民医院肾内科,湖北 武汉 430060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)])]), Author(id=1326654865369051976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654865549407050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865369051976, language=EN, stringName=Bingzheng SHEN, firstName=Bingzheng, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654865624904523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865369051976, language=CN, stringName=沈秉正, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.武汉大学人民医院药学部,湖北 武汉 430060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864710546233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=2., ext=[AuthorCompanyExt(id=1326654864727323450, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864710546233, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864752489275, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864710546233, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.武汉大学人民医院药学部,湖北 武汉 430060)])]), Author(id=1326654865696207693, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326654865792676688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865696207693, language=EN, stringName=Ke SU, firstName=Ke, middleName=null, lastName=SU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654867495564113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865696207693, language=CN, stringName=苏可, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.武汉大学人民医院肾内科,湖北 武汉 430060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)])])], keywords=[Keyword(id=1326654867654947666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=EN, orderNo=1, keyword=methylbardoxolone), Keyword(id=1326654867835302739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=EN, orderNo=2, keyword=chronic kidney disease), Keyword(id=1326654867956937556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=EN, orderNo=3, keyword=nuclear factor erythroid-related factor 2 agonist), Keyword(id=1326654868095349589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=EN, orderNo=4, keyword=glomerular filtration rate), Keyword(id=1326654868175041366, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=CN, orderNo=1, keyword=甲基巴多索隆), Keyword(id=1326654868237955927, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=CN, orderNo=2, keyword=慢性肾脏病), Keyword(id=1326654868296676184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=CN, orderNo=3, keyword=核因子红细胞系2相关因子激动剂), Keyword(id=1326654868359590745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, language=CN, orderNo=4, keyword=肾小球滤过率)], refs=[Reference(id=1326654868724495195, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=WONG MH, BRYAN HK, COPPLE IM, et al. Design and synthesis of irreversible analogues of bardoxolone methyl for the identification of pharmacologically relevant targets and interaction sites[J]. J Med Chem, 2016, 59(6): 2396-2409., articleTitle=null, refAbstract=null), Reference(id=1326654868917433180, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=SUZUKI T, YAMAMOTO M. Molecular basis of the Keap1-Nrf2 system[J]. Free Radic Biol Med, 2015, 88(Pt B): 93-100., articleTitle=null, refAbstract=null), Reference(id=1326654869169091421, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=WARDYN JD, PONSFORD AH, SANDERSON CM.Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways[J]. Biochem Soc Trans, 2015, 43(4):621-626., articleTitle=null, refAbstract=null), Reference(id=1326654869345252190, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=HONG DS, KURZROCK R, SUPKO JG, et al. A phaseⅠfirst-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas[J]. Clin Cancer Res,2012, 18(12): 3396-3406., articleTitle=null, refAbstract=null), Reference(id=1326654869466887007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=PERGOLA PE, KRAUTH M, HUFF JW, et al. Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b-4 CKD[J]. Am J Nephrol, 2011, 33(5): 469-476., articleTitle=null, refAbstract=null), Reference(id=1326654869626270560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=PERGOLA PE, RASKIN P, TOTO RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes[J].N Engl J Med, 2011, 365(4): 327-336., articleTitle=null, refAbstract=null), Reference(id=1326654869802431329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=DE ZEEUW D, AKIZAWA T, AUDHYA P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease[J]. N Engl J Med, 2013, 369(26): 2492-2503., articleTitle=null, refAbstract=null), Reference(id=1326654869865345890, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIN MP, WROLSTAD D, BAKRIS GL, et al. Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl[J]. J Card Fail, 2014, 20(12): 953-958., articleTitle=null, refAbstract=null), Reference(id=1326654869940843363, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSSING P, BLOCK GA, CHIN MP, et al. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease[J]. Kidney Int, 2019, 96(4): 1030-1036., articleTitle=null, refAbstract=null), Reference(id=1326654870016340836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=NANGAKU M, KANDA H, TAKAMA H, et al. Randomized clinical trial on the effect of bardoxolone methyl on GFR in diabetic kidney disease patients(TSUBAKI study)[J].Kidney Int Rep, 2020, 5(6): 879-890., articleTitle=null, refAbstract=null), Reference(id=1326654870087644005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=NANGAKU M, TAKAMA H, ICHIKAWA T, et al.Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study[J]. Nephrol Dial Transplant, 2023, 38(5): 1204-1216., articleTitle=null, refAbstract=null), Reference(id=1326654870146364262, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=MATSUO S, IMAI E, HORIO M, et al. Collaborators developing the japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan[J]. Am J Kidney Dis, 2009, 53(6): 982-992., articleTitle=null, refAbstract=null), Reference(id=1326654870230250343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=AKIZAWA T, YAMAWAKI K, ICHIKAWA T, et al. AYAME study: randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in diabetic kidney disease(DKD) patients[J]. Nephrol Dial Transplant, 2023,38(5): 1204-1216., articleTitle=null, refAbstract=null), Reference(id=1326654870293164904, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=PABLO P, ANJALI A, GERALD A, et al. FP117SAFETY and efficacy of bardoxolone methyl in patients with rare chronic kidney diseases[J]. Nephrol Dial Transplant, 2019,doi: 10.1093/ndt/gfz106.FP117., articleTitle=null, refAbstract=null), Reference(id=1326654870364468073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=PABLO P, ANJALI A, GERALD A, et al. FP152SAFETY and efficacy of bardoxolone methyl in patients with focal segmental glomerulosclerosis[J]. Nephrol Dial Transplant,2019, doi: 10.1093/ndt/gfz106.FP152., articleTitle=null, refAbstract=null), Reference(id=1326654872042189674, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=CHERTOW GM, APPEL GB, ANDREOLI S, et al. Study design and baseline characteristics of the CARDINAL trial: a phase 3 study of bardoxolone methyl in patients with Alport syndrome[J]. Am J Nephrol, 2021, 52(3): 180-189., articleTitle=null, refAbstract=null), Reference(id=1326654872105104235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=WARADY BA, PERGOLA PE, AGARWAL R, et al. Effects of bardoxolone methyl in Alport syndrome[J]. Clin J Am Soc Nephrol, 2022, 17(12): 1763-1774., articleTitle=null, refAbstract=null), Reference(id=1326654872184796012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=NOZU K, APPEL G, CHIN M, et al. POS-540 interim analysis of the eagle trial: an open-label study to assess the long-term safety and tolerability of bardoxolone methyl in patients with Alport syndrome[J]. Kidney Int Rep, 2022,7(2): S233-S234., articleTitle=null, refAbstract=null), Reference(id=1326654872260293485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=PERGOLA PE, APPEL GB, CHIN M, et al. Interim analysis of the EAGLE trial: an open-label study to assess the long-term safety and tolerability of bardoxolone methyl in patients with Alport syndrome[J]. J Am Soc Nephrol, 2021, 32(10S):417., articleTitle=null, refAbstract=null), Reference(id=1326654872423871343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=PERGOLA PE, KOOIENGA L, GOLDSBERRY A, et al. Results of phase 2 MERLIN: an evaluation of safety,tolerability, and efficacy of bardoxolone methyl in patients with rapidly progressing CKD: SA-PO919[J]. J Am Soc Nephrol, 2022, 33(11S): 858-858., articleTitle=null, refAbstract=null), Reference(id=1326654872499368816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=AVULA UMR, HARRIS L, HASSANEIN M. Bardoxolone for CKD: the paradox of confusion and dogma[J].Kidney360, 2022, 3(11): 1955-1960., articleTitle=null, refAbstract=null), Reference(id=1326654872570671985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BONEBRAKE L. The board and staff of Alport Syndrome Foundation(ASF) want to ensure the community of Alport patients and families are aware of the FDA's recent decision not to approve bardoxolone methyl as a treatment for Alport syndrome[EB/OL]. USA: ASF, (2022-02-25)[2024-06-12]. https://www.Alportsyndrome.org/wp-content/uploads/2022/02/ASF-Press-Release-FDA-Decision-on-Bardoloxone-Methyl-2_25_22.pdf., articleTitle=null, refAbstract=null), Reference(id=1326654872658752370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIN M, LEE CY, CHUANG JC, et al. Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of type 2 diabetes and obesity[J].Am J Physiol Renal Physiol, 2013, 304(12): F1438-F1446., articleTitle=null, refAbstract=null), Reference(id=1326654872738444147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=RUSH BM, BONDI CD, STOCKER SD, et al. Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice[J]. Kidney Int, 2021, 99(1):102-116., articleTitle=null, refAbstract=null), Reference(id=1326654872822330228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ZOJA C, CORNA D, NAVA V, et al. Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects[J]. Am J Physiol Renal Physiol, 2013,304(6): F808-F819., articleTitle=null, refAbstract=null), Reference(id=1326654872927187829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=SU K, ZHAO SL, YANG WX, et al. Nrf2 deficiency attenuates diabetic kidney disease in Db/Db mice via down-regulation of angiotensinogen, SGLT2, CD36, and FABP4 expression and lipid accumulation in renal proximal tubular cells[J]. Antioxidants(Basel), 2023, 12(9): 1715., articleTitle=null, refAbstract=null), Reference(id=1326654873057211254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO S, LO CS, MIYATA KN, et al. Overexpression of Nrf2 in renal proximal tubular cells stimulates sodium-glucose cotransporter 2 expression and exacerbates dysglycemia and kidney injury in diabetic mice[J]. Diabetes, 2021, 70(6):1388-1403., articleTitle=null, refAbstract=null), Reference(id=1326654873115931511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=KIDOKORO K, KADOYA H, CHERNEY DZI, et al. Insights into the regulation of GFR by the Keap1-Nrf2 pathway[J].Kidney360, 2023, 4(10): 1454-1466., articleTitle=null, refAbstract=null), Reference(id=1326654873183040376, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=DING Y, STIDHAM RD, BUMEISTER R, et al. The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells[J]. Kidney Int, 2013, 83(5):845-854., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326654868439282522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, awardId=2021CFB360, language=CN, fundingSource=湖北省自然科学基金(2021CFB360), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)]), AuthorCompany(id=1326654864710546233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=2., ext=[AuthorCompanyExt(id=1326654864727323450, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864710546233, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864752489275, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864710546233, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.武汉大学人民医院药学部,湖北 武汉 430060)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.04.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.04.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.04.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1744214400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
甲基巴多索隆对慢性肾脏病临床效果评价
虎璇 1 , 赵凡 1 , 沈秉正 2 , 苏可 1, *
世界临床药物 | 综述评论 2025,46(4): 411-415
收起
收藏切换
世界临床药物 |综述评论 2025 , 46 (4) : 411 -415
甲基巴多索隆对慢性肾脏病临床效果评价
全屏
[Author(id=1326654864840569662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654864945427264, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654864840569662, language=EN, stringName=Xuan HU, firstName=Xuan, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654865008341825, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654864840569662, language=CN, stringName=虎璇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.武汉大学人民医院肾内科,湖北 武汉 430060, bio={"content":"

虎璇,硕士研究生,研究方向:糖尿病肾病诊治。

"}, bioImg=null, bioContent=

虎璇,硕士研究生,研究方向:糖尿病肾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)])]), Author(id=1326654865088033603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654865234834245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865088033603, language=EN, stringName=Fan ZHAO, firstName=Fan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654865293554502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865088033603, language=CN, stringName=赵凡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.武汉大学人民医院肾内科,湖北 武汉 430060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)])]), Author(id=1326654865369051976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326654865549407050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865369051976, language=EN, stringName=Bingzheng SHEN, firstName=Bingzheng, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654865624904523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865369051976, language=CN, stringName=沈秉正, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.武汉大学人民医院药学部,湖北 武汉 430060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864710546233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=2., ext=[AuthorCompanyExt(id=1326654864727323450, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864710546233, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864752489275, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864710546233, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.武汉大学人民医院药学部,湖北 武汉 430060)])]), Author(id=1326654865696207693, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326654865792676688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865696207693, language=EN, stringName=Ke SU, firstName=Ke, middleName=null, lastName=SU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326654867495564113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, authorId=1326654865696207693, language=CN, stringName=苏可, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.武汉大学人民医院肾内科,湖北 武汉 430060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326654864618271542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, xref=1., ext=[AuthorCompanyExt(id=1326654864639243063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China), AuthorCompanyExt(id=1326654864647631672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326654863930405682, companyId=1326654864618271542, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.武汉大学人民医院肾内科,湖北 武汉 430060)])])]
虎璇1, 赵凡1, 沈秉正2, 苏可1, *
作者信息
  • 1.武汉大学人民医院肾内科,湖北 武汉 430060
  • 2.武汉大学人民医院药学部,湖北 武汉 430060
通讯作者:
苏可,硕士生导师,副主任医师,研究方向:糖尿病肾病诊治。
作者简介:

虎璇,硕士研究生,研究方向:糖尿病肾病诊治。

Evaluation of the clinical efficacy of methylbardoxolone in the treatment of chronic kidney disease
Xuan HU1, Fan ZHAO1, Bingzheng SHEN2, Ke SU1, *
Affiliations
  • 1.Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China
  • 2.Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China
出版时间: 2025-04-10 doi: 10.13683/j.wph.2025.04.015
文章导航
收藏切换

氧化应激和炎症是导致慢性肾脏病(chronic kidney disease,CKD)进展至终末期肾病(end-stage renal disease,ESRD)的共同因素,而甲基巴多索隆是一种抗氧化和抗炎因子核因子红细胞系2相关因子激动剂,可提高CKD患者肾小球滤过率,但因其可增加心血管事件、蛋白尿发生风险,未能改善ESRD发生率,故最终未能成为CKD治疗药物。现综述甲基巴多索隆在多种因素引发的CKD药物临床试验中的影响,旨在为临床应用提供参考。

甲基巴多索隆  /  慢性肾脏病  /  核因子红细胞系2相关因子激动剂  /  肾小球滤过率

Oxidative stress and inflammation are common factors that lead to the progression of chronic kidney disease (CKD) to end-stage renal disease (ESRD), and methylbardoxolone is an agonist of antioxidant and anti-inflammatory factors such nuclear factor erythroid-related factor 2. It can increase the glomerular filtration rate (GFR) of patients with CKD. Methylbardoxolone has a good effect in increasing GFR. However, because it can increase the risk of cardiovascular events and proteinuria, and fails to improve the incidence of ESRD, it ultimately failed to become a therapeutic drug for CKD. This article reviewed the effects of methylbardoxolone in clinical trials of CKD drugs caused by multiple factors, aiming to provide a reference for its application.

methylbardoxolone  /  chronic kidney disease  /  nuclear factor erythroid-related factor 2 agonist  /  glomerular filtration rate
虎璇, 赵凡, 沈秉正, 苏可. 甲基巴多索隆对慢性肾脏病临床效果评价. 世界临床药物, 2025 , 46 (4) : 411 -415 . DOI: 10.13683/j.wph.2025.04.015
Xuan HU, Fan ZHAO, Bingzheng SHEN, Ke SU. Evaluation of the clinical efficacy of methylbardoxolone in the treatment of chronic kidney disease[J]. World Clinical Drug, 2025 , 46 (4) : 411 -415 . DOI: 10.13683/j.wph.2025.04.015
  • 湖北省自然科学基金(2021CFB360)
参考文献 引证文献
排序方式:
[1]
WONG MH, BRYAN HK, COPPLE IM, et al. Design and synthesis of irreversible analogues of bardoxolone methyl for the identification of pharmacologically relevant targets and interaction sites[J]. J Med Chem, 2016, 59(6): 2396-2409.
[2]
SUZUKI T, YAMAMOTO M. Molecular basis of the Keap1-Nrf2 system[J]. Free Radic Biol Med, 2015, 88(Pt B): 93-100.
[3]
WARDYN JD, PONSFORD AH, SANDERSON CM.Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways[J]. Biochem Soc Trans, 2015, 43(4):621-626.
[4]
HONG DS, KURZROCK R, SUPKO JG, et al. A phaseⅠfirst-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas[J]. Clin Cancer Res,2012, 18(12): 3396-3406.
[5]
PERGOLA PE, KRAUTH M, HUFF JW, et al. Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b-4 CKD[J]. Am J Nephrol, 2011, 33(5): 469-476.
[6]
PERGOLA PE, RASKIN P, TOTO RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes[J].N Engl J Med, 2011, 365(4): 327-336.
[7]
DE ZEEUW D, AKIZAWA T, AUDHYA P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease[J]. N Engl J Med, 2013, 369(26): 2492-2503.
[8]
CHIN MP, WROLSTAD D, BAKRIS GL, et al. Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl[J]. J Card Fail, 2014, 20(12): 953-958.
[9]
ROSSING P, BLOCK GA, CHIN MP, et al. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease[J]. Kidney Int, 2019, 96(4): 1030-1036.
[10]
NANGAKU M, KANDA H, TAKAMA H, et al. Randomized clinical trial on the effect of bardoxolone methyl on GFR in diabetic kidney disease patients(TSUBAKI study)[J].Kidney Int Rep, 2020, 5(6): 879-890.
[11]
NANGAKU M, TAKAMA H, ICHIKAWA T, et al.Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study[J]. Nephrol Dial Transplant, 2023, 38(5): 1204-1216.
[12]
MATSUO S, IMAI E, HORIO M, et al. Collaborators developing the japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan[J]. Am J Kidney Dis, 2009, 53(6): 982-992.
[13]
AKIZAWA T, YAMAWAKI K, ICHIKAWA T, et al. AYAME study: randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in diabetic kidney disease(DKD) patients[J]. Nephrol Dial Transplant, 2023,38(5): 1204-1216.
[14]
PABLO P, ANJALI A, GERALD A, et al. FP117SAFETY and efficacy of bardoxolone methyl in patients with rare chronic kidney diseases[J]. Nephrol Dial Transplant, 2019,doi: 10.1093/ndt/gfz106.FP117.
[15]
PABLO P, ANJALI A, GERALD A, et al. FP152SAFETY and efficacy of bardoxolone methyl in patients with focal segmental glomerulosclerosis[J]. Nephrol Dial Transplant,2019, doi: 10.1093/ndt/gfz106.FP152.
[16]
CHERTOW GM, APPEL GB, ANDREOLI S, et al. Study design and baseline characteristics of the CARDINAL trial: a phase 3 study of bardoxolone methyl in patients with Alport syndrome[J]. Am J Nephrol, 2021, 52(3): 180-189.
[17]
WARADY BA, PERGOLA PE, AGARWAL R, et al. Effects of bardoxolone methyl in Alport syndrome[J]. Clin J Am Soc Nephrol, 2022, 17(12): 1763-1774.
[18]
NOZU K, APPEL G, CHIN M, et al. POS-540 interim analysis of the eagle trial: an open-label study to assess the long-term safety and tolerability of bardoxolone methyl in patients with Alport syndrome[J]. Kidney Int Rep, 2022,7(2): S233-S234.
[19]
PERGOLA PE, APPEL GB, CHIN M, et al. Interim analysis of the EAGLE trial: an open-label study to assess the long-term safety and tolerability of bardoxolone methyl in patients with Alport syndrome[J]. J Am Soc Nephrol, 2021, 32(10S):417.
[20]
PERGOLA PE, KOOIENGA L, GOLDSBERRY A, et al. Results of phase 2 MERLIN: an evaluation of safety,tolerability, and efficacy of bardoxolone methyl in patients with rapidly progressing CKD: SA-PO919[J]. J Am Soc Nephrol, 2022, 33(11S): 858-858.
[21]
AVULA UMR, HARRIS L, HASSANEIN M. Bardoxolone for CKD: the paradox of confusion and dogma[J].Kidney360, 2022, 3(11): 1955-1960.
[22]
BONEBRAKE L. The board and staff of Alport Syndrome Foundation(ASF) want to ensure the community of Alport patients and families are aware of the FDA's recent decision not to approve bardoxolone methyl as a treatment for Alport syndrome[EB/OL]. USA: ASF, (2022-02-25)[2024-06-12]. https://www.Alportsyndrome.org/wp-content/uploads/2022/02/ASF-Press-Release-FDA-Decision-on-Bardoloxone-Methyl-2_25_22.pdf.
[23]
CHIN M, LEE CY, CHUANG JC, et al. Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of type 2 diabetes and obesity[J].Am J Physiol Renal Physiol, 2013, 304(12): F1438-F1446.
[24]
RUSH BM, BONDI CD, STOCKER SD, et al. Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice[J]. Kidney Int, 2021, 99(1):102-116.
[25]
ZOJA C, CORNA D, NAVA V, et al. Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects[J]. Am J Physiol Renal Physiol, 2013,304(6): F808-F819.
[26]
SU K, ZHAO SL, YANG WX, et al. Nrf2 deficiency attenuates diabetic kidney disease in Db/Db mice via down-regulation of angiotensinogen, SGLT2, CD36, and FABP4 expression and lipid accumulation in renal proximal tubular cells[J]. Antioxidants(Basel), 2023, 12(9): 1715.
[27]
ZHAO S, LO CS, MIYATA KN, et al. Overexpression of Nrf2 in renal proximal tubular cells stimulates sodium-glucose cotransporter 2 expression and exacerbates dysglycemia and kidney injury in diabetic mice[J]. Diabetes, 2021, 70(6):1388-1403.
[28]
KIDOKORO K, KADOYA H, CHERNEY DZI, et al. Insights into the regulation of GFR by the Keap1-Nrf2 pathway[J].Kidney360, 2023, 4(10): 1454-1466.
[29]
DING Y, STIDHAM RD, BUMEISTER R, et al. The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells[J]. Kidney Int, 2013, 83(5):845-854.
2025年第46卷第4期
65
10
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.04.015
  • 接收时间:2024-08-28
  • 首发时间:2026-11-09
  • 出版时间:2025-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-08-28
  • 修回日期:2025-02-12
基金
湖北省自然科学基金(2021CFB360)
作者信息
    1.武汉大学人民医院肾内科,湖北 武汉 430060
    2.武汉大学人民医院药学部,湖北 武汉 430060

通讯作者:

苏可,硕士生导师,副主任医师,研究方向:糖尿病肾病诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.04.015
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏